Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.26 Billion | 9.58 Billion | 10.53 Billion | 7.9 Billion | 6.13 Billion | 6.3 Billion |
| Net Income | 5.7 Billion | 6.93 Billion | 7.07 Billion | 4.49 Billion | 3.68 Billion | 2.36 Billion |
| Depreciation & Amortization | 3.24 Billion | 3.26 Billion | 3.53 Billion | 3.32 Billion | 3.01 Billion | 3.27 Billion |
| Deferred income taxes | -8.47 Billion | - | - | - | - | 293 Million |
| Stock-based compensation | 644 Million | 685 Million | 640 Million | 546 Million | 519 Million | 477 Million |
| Change in working capital | -2.47 Billion | -1.51 Billion | -771 Million | -892 Million | -1.33 Billion | -148 Million |
| Other non-cash items | 8.62 Billion | 215 Million | 55 Million | 425 Million | 247 Million | 32 Million |
| Investing Cash Flow | -3.13 Billion | -1.74 Billion | -2 Billion | -2.21 Billion | -1.81 Billion | -1.35 Billion |
| Investments in PPE | -2.2 Billion | -1.77 Billion | -1.88 Billion | -2.17 Billion | -1.63 Billion | -1.39 Billion |
| Acquisitions | -837 Million | 48 Million | -53 Million | 16 Million | -122 Million | 48 Million |
| Investment purchases | -159 Million | -185 Million | -173 Million | -83 Million | -103 Million | -131 Million |
| Sales/Maturities of investments | 43 Million | 152 Million | 77 Million | 10 Million | 21 Million | 73 Million |
| Other Investing Activities | 22 Million | 22 Million | 26 Million | 19 Million | 27 Million | 48 Million |
| Financing Cash Flow | -7.09 Billion | -7.63 Billion | -5.49 Billion | -2.77 Billion | -4.28 Billion | -10.39 Billion |
| Debt repayment | -2.47 Billion | -753 Million | -48 Million | -1.33 Billion | -3.44 Billion | -12.43 Billion |
| Dividends payments | -3.55 Billion | -3.3 Billion | -3.2 Billion | -2.56 Billion | -2.27 Billion | -1.97 Billion |
| Common Stock Repurchased | -1.22 Billion | -3.79 Billion | -2.29 Billion | -403 Million | -718 Million | -238 Million |
| Common Stock Issuance | 167 Million | 167 Million | 255 Million | 1.52 Billion | 298 Million | 271 Million |
| Other Financing Activities | -2.28 Billion | 54 Million | -200 Million | -11 Million | 1.84 Billion | 4.25 Billion |
| Accounts receivables | -356 Million | -68 Million | -383 Million | -924 Million | -275 Million | -190 Million |
| Accounts payables | -760 Million | 420 Million | 1.28 Billion | 1.76 Billion | 220 Million | 747 Million |
| Inventory | -232 Million | -1.41 Billion | -456 Million | -493 Million | -593 Million | -514 Million |
| Other working capital | -1.12 Billion | -458 Million | -1.22 Billion | -1.24 Billion | -683 Million | -191 Million |
| Cash at beginning of period | 9.88 Billion | 9.79 Billion | 6.83 Billion | 3.86 Billion | 3.84 Billion | 9.4 Billion |
| Cash at end of period | 6.89 Billion | 9.88 Billion | 9.79 Billion | 6.83 Billion | 3.86 Billion | 3.84 Billion |
| Capital Expenditure | -2.2 Billion | -1.77 Billion | -1.88 Billion | -2.17 Billion | -1.63 Billion | -1.39 Billion |
| Effect of forex changes on cash | -23 Million | -122 Million | -70 Million | 71 Million | -16 Million | -116 Million |
| Net cash flow / Change in cash | -2.98 Billion | 83 Million | 2.96 Billion | 2.97 Billion | 16 Million | -5.56 Billion |
| Free Cash Flow | 5.05 Billion | 7.8 Billion | 8.64 Billion | 5.72 Billion | 4.49 Billion | 4.9 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 1.29 Billion | 1.22 Billion | 1.58 Billion | 5.7 Billion | 1.43 Billion |
| Depreciation & Amortization | - | 805 Million | 805 Million | 813 Million | 3.24 Billion | 824 Million |
| Deferred income taxes | - | - | - | -1.37 Billion | -8.47 Billion | - |
| Stock-based compensation | - | 141 Million | 304 Million | 114 Million | 644 Million | 117 Million |
| Change in working capital | - | -288 Million | -1.3 Billion | 391 Million | -2.47 Billion | -321 Million |
| Other non-cash items | - | 2.18 Billion | 2.48 Billion | 1.5 Billion | 8.62 Billion | -179 Million |
| Investing Cash Flow | - | -453 Million | -425 Million | -824 Million | -3.13 Billion | -634 Million |
| Investments in PPE | - | -533 Million | -398 Million | -755 Million | -2.2 Billion | -560 Million |
| Acquisitions | - | 1 Million | - | -40 Million | -837 Million | -51 Million |
| Investment purchases | - | 28 Million | -28 Million | -114 Million | -159 Million | -38 Million |
| Sales/Maturities of investments | - | 49 Million | - | 43 Million | 43 Million | 38 Million |
| Other Investing Activities | - | 2 Million | 1 Million | 2 Million | 22 Million | -23 Million |
| Financing Cash Flow | - | -791 Million | -1.17 Billion | -2.05 Billion | -7.09 Billion | -2.34 Billion |
| Debt repayment | - | -160 Million | -127 Million | -939 Million | -2.47 Billion | -1.44 Billion |
| Dividends payments | - | -961 Million | -957 Million | -888 Million | -3.55 Billion | -888 Million |
| Common Stock Repurchased | - | -3 Million | -226 Million | -259 Million | -1.22 Billion | -2 Million |
| Common Stock Issuance | - | 13 Million | 134 Million | 34 Million | 167 Million | 56 Million |
| Other Financing Activities | - | 173 Million | 7 Million | 145 Million | -2.28 Billion | -61 Million |
| Accounts receivables | - | -325 Million | -151 Million | 68 Million | -356 Million | -461 Million |
| Accounts payables | - | - | - | -1.34 Billion | -760 Million | 179 Million |
| Inventory | - | -103 Million | -410 Million | 295 Million | -232 Million | 140 Million |
| Other working capital | - | 140 Million | -748 Million | 1.37 Billion | -1.12 Billion | -179 Million |
| Cash at beginning of period | - | 6.28 Billion | 6.89 Billion | 6.7 Billion | 9.88 Billion | 7.83 Billion |
| Cash at end of period | - | 6.98 Billion | 6.28 Billion | 6.89 Billion | 6.89 Billion | 6.7 Billion |
| Capital Expenditure | - | -533 Million | -398 Million | -755 Million | -2.2 Billion | -560 Million |
| Effect of forex changes on cash | - | -13 Million | -36 Million | 25 Million | -23 Million | -29 Million |
| Net cash flow / Change in cash | - | 703 Million | -612 Million | 187 Million | -2.98 Billion | -1.12 Billion |
| Free Cash Flow | - | 1.42 Billion | 627 Million | 2.28 Billion | 5.05 Billion | 1.31 Billion |
AFL
600578
002436
MITT-PB
FXNC
1201